Stubborn inflation data has the Federal Reserve anticipating only two rate cuts in 2025. That’s why investors are watching the November PCE report closely, given that it is the Fed’s preferred inflation gauge. The data for the month was cooler than expected, rising 2.4% from last year. The core reading showed inflation rose 2.8% year over year. One of the biggest movers is Novo Nordisk (NVO). The company released a study that showed its experimental obesity drug helped patients lose weight, but not as much as hoped. Other trending tickers include Nike (NKE), FedEx (FDX), and Eli Lilly (LLY).
Key guests include:
9:05 a.m. ET - Victoria Fernandez, Crossmark Global Investments Chief Market Strategist
10:00 a.m. ET - John Stoltzfus, Oppenheimer & Co. Chief Investment Strategist
10:15 a.m. ET - Yung-Yu Ma, BMO Wealth Management, U.S. Chief Investment Officer
10:30 a.m. ET - Isaac Stone Fish, Strategy Risks Founder and CEO
11:10 a.m. ET - Andrew Kadjeski, Vanguard Head of Brokerage & Investments